Yıl: 2013 Cilt: 12 Sayı: 2 Sayfa Aralığı: 199 - 208 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Toxoplasma gondii, ruh sağlığı ve şizofreni

Öz:
Ruhsal sağlığın korunması ve geliştirilmesi Halk Sağlığı’nın önemli uğraş alanlarından birisidir. Özellikle, Toxoplasma gondii, Türkiye’de yaygın görülen paraziter-protozoal bir zoonoz olup, veteriner halk sağlığını yakından ilgilendirmektedir. Son yıllarda T. gondii’nin davranış değişikliklerine yol açabildiği, şizofrenide etyolojik bir faktör olarak rol oynayabileceği, intihar gibi durumlarda neden olabileceği yönünde çalışmalar yapılmaktadır. Bu derlemenin amacı, T. gondii epidemiyolojisi, ruhsal sağlığa etkileri (davranış değişiklikleri, intihar, vb.) ve şizofreni gelişimi ile ilgili çalışmaların sonuçları hakkında bilgi vermek ve halk sağlığının korunması için bazı öneriler sunmaktır.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Toxoplasma gondii, mental health and shizophrenia

Öz:
Protecting and promoting of mental health is one of the major application areas of public health. In particular, Toxoplasma gondii, which is a protozoal zoonosis common in Turkey, it is closely related to veterinary public health. In recent years, T.gondii can induce behavioral changes, may play a role in schizophrenia as an etiologic factor. Results of the recently performed studies shows that T.gondii may be a potential factor for some neuropathological changes in brain and suicide attemption. The purpose of this review is to present the data on recent epidemiology of T.gondii, mental health effects (changes in behavior, suicide, etc.), the relationship between T.gondii and schizophrenia and offer some recommendations for protecting of public health.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH. Early Infections of Toxoplasma gondii and the Later Development of Schizophrenia. Schizophr Bull. 2007; 33(3): 741-744. http://dx.doi.org/10.1093/schbul/sbm009 [Pubmed] [PMC Free Fulltext]
  • 2. Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004; 61: 774-780. http://dx.doi.org/10.1001/archpsyc.61.8.774 [Pubmed]
  • 3. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006; 32(2): 200-2. http://dx.doi.org/10.1093/schbul/sbj052 [Pubmed] [PMC Free Fulltext]
  • 4. Leweke FM, Gerth CW, Koethe D, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004; 254: 4-8. http://dx.doi.org/10.1007/s00406-004-0481-6 [Pubmed]
  • 5. Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res. 2011; 128(1-3): 61-5. http://dx.doi.org/10.1016/j.schres.2011.01.020 [Pubmed]
  • 6. Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand. 2006; 114(1): 40-48. http://dx.doi.org/10.1111/j.1600-0447.2006.00780.x [Pubmed]
  • 7. Bachmann S, Schroder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology. 2005; 38(2): 87-90. http://dx.doi.org/10.1159/000085349 [Pubmed]
  • 8. Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry. 2008; 165(1): 99-106. http://dx.doi.org/10.1176/appi.ajp.2007.06081254 [Pubmed]
  • 9. Binbay T, Ulaþ H, Alptekin K. Þizofreni Epidemiyolojisine Turkiye'den Katki Yapmak: Nasil ve Neden? Klinik Psikiyatri. 2010; 13(Ek 1): 9-15.
  • 10. Binbay T, Ulaþ H, Alptekin K, Elbi H. Bati Avrupa Ülkelerinde Yaþayan Turkiye Kokenli Goçmenlerde Psikotik Bozukluklar: Siklik, Yayginlik ve Baþvuru Oranlari Üzerine Bir Derleme. Turk Psikiyatri Derg. 2012; 23(1): 53-2. [Pubmed]
  • 11. Alptekin K, Ulas H, Akdede BB, et al. Prevalence and risk factors of psychotic symptoms: in the city of Izmir, Turkey. Soc Psychiatry Psychiatr Epidemiol. 2009; 44: 905-910. http://dx.doi.org/10.1007/s00127-009-0012-x [Pubmed]
  • 12. Okusaga O, Langenberg P, Sleemi A, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res. 2011; 133(1-3): 150-155. http://dx.doi.org/10.1016/j.schres.2011.08.006 [Pubmed]
  • 13. Horacek J, Flegr J, Tintera J, et al. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: Voxel-based-morphometry (VBM) study. World J Biol Psychiatry. 2011 May 23. [Epub ahead of print] [Pubmed]
  • 14. Ahmad D, Mehdi S, Sayed HH, Sayed AK, Shirzad G. Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Trop Biomed. 2010; 27(3): 476-482. [Pubmed]
  • 15. Zhu S. Psychosis may be associated with toxoplasmosis. Med Hypotheses 2009; 73(5): 799-801. http://dx.doi.org/10.1016/j.mehy.2009.04.013 [Pubmed]
  • 16. da Silva RC, Langoni H. Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res. 2009; 105(4): 893-898. http://dx.doi.org/10.1007/s00436-009-1526-6 [Pubmed]
  • 17. Yolken RH, Dickerson FB, Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol. 2009; 31(11): 706-715. http://dx.doi.org/10.1111/j.1365-3024.2009.01131.x [Pubmed]
  • 18. Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis. 2011; 199(7): 440-444. http://dx.doi.org/10.1097/NMD.0b013e318221416e [Pubmed] [PMC Free Fulltext]
  • 19. Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders--overview of evidence and mechanisms. Folia Parasitol (Praha). 2010; 57(2): 105-113.
  • 20. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii Antibodies in Patients With Schizophrenia—Preliminary Findings in a Turkish Sample. Schizophr Bull. 2007; 33(3): 789-91. http://dx.doi.org/10.1093/schbul/sbm021 [Pubmed] [PMC Free Fulltext]
  • 21. Tamer GS, Dundar D, Yalug I, Caliskan S, Yazar S, Aker A. The schizophrenia and Toxoplasma gondii connection: infectious, immune or both? Adv Ther. 2008; 25(7): 703-709. http://dx.doi.org/10.1007/s12325-008-0063-5 [Pubmed]
  • 22. Yuksel P, Alpay N, Babur C, et al. The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia--the risk factor or an indication of a contact with cat? Folia Parasitol (Praha). 2010; 57(2): 121-8.
  • 23. Gokçe C, Yazar S, Bayram F, Gundogan K. Toxoplasma gondii Antibodies in Type 1 Diabetes Mellitus. Turkiye Klinikleri J Med Sci. 2008; 28: 619-22.
  • 24. Flegr J. Effects of Toxoplasma on Human Behavior. Schizophr Bull. 2007; 33(3): 757-60. http://dx.doi.org/10.1093/schbul/sbl074 [Pubmed] [PMC Free Fulltext]
  • 25. Tansel Ö, Ekuklu G, Kunduracilar H, Eker A, Yulugkural Z, Yuksel P. Edirne’de dogurganlik çagindaki kadinlarda toksoplazmoz seroepidemiyolojisi ve teorik konjenital toksoplazmoz insidansinin belirlenmesi: Toplum tabanli bir çaliþma. Turkiye Klinikleri J Med Sci. 2009; 29(1): 84-90.
  • 26. Can ÖS, Yalçin Þ, Memikoglu O, Özgencil E, Oba Þ, Tulunay M, et al. A Trojan Horse in Intensive Care Unit: Toxoplasma gondii. Turkiye Klinikleri J Med Sci. 2012; 32(1): 120-3. http://dx.doi.org/10.5336/medsci.2011-23054
  • 27. Kaptan F, Örmen B, Turker N, El S, Ural S, Vardar Ý, et al. Retrospective Evaluation of 128 Cases Infected with Human Immunodeficiency Virus. Turkiye Klinikleri J Med Sci. 2011; 31(3): 525-33. http://dx.doi.org/10.5336/medsci.2010-18889
  • 28. Shin DW, Cha DY, Hua QJ, Cha GH, Lee YH. Seroprevalence of Toxoplasma gondii Infection and Characteristics of Seropositive Patients in General Hospitals in Daejeon, Korea. Korean J Parasitol. 2009; 47(2): 125-130. http://dx.doi.org/10.3347/kjp.2009.47.2.125 [Pubmed] [PMC Free Fulltext]
  • 29. Ajioka JW, Soldati D. Toxoplasma-Molecular and Cellular Biology. Norfolk, UK. Horizon Bioscience. 2007; 37-58.
  • 30. T.C. Saglik Bakanligi Temel Saglik Hizmetleri Genel Mudurlugu Zoonotik Hastaliklar Daire Baþkanligi. Zoonotik Hastaliklar Hizmet Ýçi Egitim Modulu. Ankara, 2011. S.167. ISBN: 978-975-590-328-326. http://sbu.saglik.gov.tr/Ekutuphane/kitaplar/Zoonotik%20Hastaliklar%20Katilimci%20Kitabi.pdf [Eriþim tarihi: 17.01.2012]
  • 31. Torrey EF, Yolken RH. Editors’ Introduction: Schizophrenia and Toxoplasmosis. Schizophr Bull. 2007; 33(3): 727-728. http://dx.doi.org/10.1093/schbul/sbm026 [Pubmed] [PMC Free Fulltext]
  • 32. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis. Schizophr Bull. 2007; 33(3): 729-736. http://dx.doi.org/10.1093/schbul/sbl050 [Pubmed] [PMC Free Fulltext]
  • 33. Yuan Z, Gao S, Liu Q, Xia X, Liu X, Liu B, Hu R. Toxoplasma gondii antibodies in cancer patients. Cancer Lett. 2007; 254: 71-4. http://dx.doi.org/10.1016/j.canlet.2007.02.011 [Pubmed]
  • 34. Yolken RH, Bachmann S, Rouslanova I, et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001; 32: 842-844. http://dx.doi.org/10.1086/319221 [Pubmed]
  • 35. Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R. Toxoplasma gondii in individuals with schizophrenia: Association with clinical and demographic factors and with mortality. Schizophr Bull. 2007; 33(3): 737-740. http://dx.doi.org/10.1093/schbul/sbm005 [Pubmed] [PMC Free Fulltext]
  • 36. Alvarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O, Dubey JP. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int. 2011; 60(2): 151-155. http://dx.doi.org/10.1016/j.parint.2010.12.003 [Pubmed]
  • 37. Pedersen MG, Stevens H, Pedersen CB, Pedersen BN, Mortensen PB. Toxoplasma Infection and Later Development of Schizophrenia in Mothers. Am J Psychiatry. 2011; 168(8): 814-821. http://dx.doi.org/10.1176/appi.ajp.2011.10091351 [Pubmed]
  • 38. Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res. 2008; 106(2-3): 268-274. http://dx.doi.org/10.1016/j.schres.2008.07.017 [Pubmed] [PMC Free Fulltext]
  • 39. Wang H, Yolken RH, Hoekstra PJ, Burger H, Klein HC. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: The TRAILS study. Schizophr Res. 2011; 129(1): 47-51. http://dx.doi.org/10.1016/j.schres.2011.03.013 [Pubmed]
  • 40. Hinze-Selch D, Da¨ubener W, Eggert L, Erdag Þ, Stoltenberg R, Wilms S. A Controlled Prospective Study of Toxoplasma gondii Infection in Individuals With Schizophrenia: Beyond Seroprevalence. Schizophr Bull. 2007; 33(3): 782-788. http://dx.doi.org/10.1093/schbul/sbm010 [Pubmed] [PMC Free Fulltext]
  • 41. Vern B. Carruthers and Yasuhiro Suzuki. Effects of Toxoplasma gondii Infection on the Brain. Schizophr Bull. 2007; 33(3): 745-751. http://dx.doi.org/10.1093/schbul/sbm008 [Pubmed] [PMC Free Fulltext]
  • 42. Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006; 33: 270-298. http://dx.doi.org/10.1053/j.seminoncol.2006.03.008 [Pubmed]
  • 43. Sakic B, Kirkham DL, Ballok DA, et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol. 2005; 169: 68-85. http://dx.doi.org/10.1016/j.jneuroim.2005.08.010 [Pubmed] [PMC Free Fulltext]
  • 44. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001; 7: 1189-1193. http://dx.doi.org/10.1038/nm1101-1189 [Pubmed]
  • 45. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA. 2006; 103: 678-683. http://dx.doi.org/10.1073/pnas.0510055103 [Pubmed] [PMC Free Fulltext]
  • 46. Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, et al. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J. 2011; 49(3): 211-220. [Pubmed]
  • 47. Muller N, Schwarz MJ. Immunology in schizophrenic disorders. Nervenarzt. 2007; 78(3): 253-256. http://dx.doi.org/10.1007/s00115-006-2108-9 [Pubmed]
  • 48. Kosugi I, Kawasaki H, Tsuchida T, Tsutsui Y. Cytomegalovirus infection inhibits the expression of N-methyl-Daspartate receptors in the developing mouse hippocampus and primary neuronal cultures. Acta Neuropathol (Berl). 2005; 109: 475-82. http://dx.doi.org/10.1007/s00401-005-0987-7 [Pubmed]
  • 49. Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol. 2004; 190(Suppl 1): 8-21. http://dx.doi.org/10.1016/j.expneurol.2004.03.027 [Pubmed]
  • 50. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol. 1985; 79: 153-157. [Pubmed]
  • 51. Över L, Aksoy Ü. Parazitler canlilarin davraniþlari uzerine etkili mi? DEÜ Tip Fakultesi Dergisi. 2006; 20(2): 115-123.
  • 52. Hrda S, Votypka J, Kodym P, Flegr J. Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J Parasitol. 2000; 86: 657-63. [Pubmed]
  • 53. Yereli K, Balcioglu IC, Ozbilgin A. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci Int. 2006; 163: 34-7. http://dx.doi.org/10.1016/j.forsciint.2005.11.002 [Pubmed]
  • 54. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation. 2009; 16(2): 122-33. http://dx.doi.org/10.1159/000180267 [Pubmed]
  • 55. Skallova A, Frynta D, Kodym P, Flegr J. The role of dopamin in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology. 2006; 133: 525-35. http://dx.doi.org/10.1017/S0031182006000886 [Pubmed]
  • 56. Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003; 63: 253-268. http://dx.doi.org/10.1016/S0301-0511(03)00075-9
  • 57. Novotna M, Hanusova J, Klose J, et al. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect Dis. 2005; 5: 54. http://dx.doi.org/10.1186/1471-2334-5-54 [Pubmed] [PMC Free Fulltext]
  • 58. Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P. Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem. 1993; 61: 1284-1290. http://dx.doi.org/10.1111/j.1471-4159.1993.tb13620.x [Pubmed]
  • 59. Petitto JM, McCarthy DB, Rinker CM, Huang Z, Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J Neuroimmunol. 1997; 73: 183-90. http://dx.doi.org/10.1016/S0165-5728(96)00196-8
  • 60. Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science. 2002; 296: 692-695. http://dx.doi.org/10.1126/science.1070532 [Pubmed]
  • 61. Webster JP. The Effect of Toxoplasma gondii on Animal Behavior: Playing Cat and Mouse. Schizophr Bull. 2007; 33(3): 752-756. http://dx.doi.org/10.1093/schbul/sbl073 [Pubmed] [PMC Free Fulltext]
  • 62. Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG. Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Physiol. 1997; 272: 908-917.
  • 63. Adamec RE, Burton P, Shallow T, Budgell J. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure—implications for anxiety associated with posttraumatic stress disorder. Physiol Behav. 1999; 65: 723-737. http://dx.doi.org/10.1016/S0031-9384(98)00226-1
  • 64. Blanchard RJ, Blanchard DC, Rodgers J, Weiss SM. The characterization and modelling of antipredator defensive behavior. Neurosci Biobehav Rev. 1990; 14: 463-472. http://dx.doi.org/10.1016/S0149-7634(05)80069-7
  • 65. Webster JP, Lamberton PHL, Donnelly CA, Torrey EF. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-protozoan medication on T. gondii’s ability to alter host behaviour. Proc Biol Sci. 2006; 273: 1023-30. http://dx.doi.org/10.1098/rspb.2005.3413 [Pubmed] [PMC Free Fulltext]
  • 66. Goodwin DG, Strobl JS, Lindsay DS. Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures. J Parasitol. 2011; 97(1): 148-151. http://dx.doi.org/10.1645/GE-2536.1 [Pubmed]
  • 67. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003; 62(3): 237-244. http://dx.doi.org/10.1016/S0920-9964(02)00357-2
  • 68. Boothroyd JC, Grigg ME. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol. 2002; 5: 438-442. http://dx.doi.org/10.1016/S1369-5274(02)00349-1
APA CEVİZCİ S, Babaoğlu Ü, ÖTEKÇİN GÜLEÇ D (2013). Toxoplasma gondii, ruh sağlığı ve şizofreni. , 199 - 208.
Chicago CEVİZCİ Sibel,Babaoğlu Ülken Tunga,ÖTEKÇİN GÜLEÇ Demet Toxoplasma gondii, ruh sağlığı ve şizofreni. (2013): 199 - 208.
MLA CEVİZCİ Sibel,Babaoğlu Ülken Tunga,ÖTEKÇİN GÜLEÇ Demet Toxoplasma gondii, ruh sağlığı ve şizofreni. , 2013, ss.199 - 208.
AMA CEVİZCİ S,Babaoğlu Ü,ÖTEKÇİN GÜLEÇ D Toxoplasma gondii, ruh sağlığı ve şizofreni. . 2013; 199 - 208.
Vancouver CEVİZCİ S,Babaoğlu Ü,ÖTEKÇİN GÜLEÇ D Toxoplasma gondii, ruh sağlığı ve şizofreni. . 2013; 199 - 208.
IEEE CEVİZCİ S,Babaoğlu Ü,ÖTEKÇİN GÜLEÇ D "Toxoplasma gondii, ruh sağlığı ve şizofreni." , ss.199 - 208, 2013.
ISNAD CEVİZCİ, Sibel vd. "Toxoplasma gondii, ruh sağlığı ve şizofreni". (2013), 199-208.
APA CEVİZCİ S, Babaoğlu Ü, ÖTEKÇİN GÜLEÇ D (2013). Toxoplasma gondii, ruh sağlığı ve şizofreni. TSK Koruyucu Hekimlik Bülteni, 12(2), 199 - 208.
Chicago CEVİZCİ Sibel,Babaoğlu Ülken Tunga,ÖTEKÇİN GÜLEÇ Demet Toxoplasma gondii, ruh sağlığı ve şizofreni. TSK Koruyucu Hekimlik Bülteni 12, no.2 (2013): 199 - 208.
MLA CEVİZCİ Sibel,Babaoğlu Ülken Tunga,ÖTEKÇİN GÜLEÇ Demet Toxoplasma gondii, ruh sağlığı ve şizofreni. TSK Koruyucu Hekimlik Bülteni, vol.12, no.2, 2013, ss.199 - 208.
AMA CEVİZCİ S,Babaoğlu Ü,ÖTEKÇİN GÜLEÇ D Toxoplasma gondii, ruh sağlığı ve şizofreni. TSK Koruyucu Hekimlik Bülteni. 2013; 12(2): 199 - 208.
Vancouver CEVİZCİ S,Babaoğlu Ü,ÖTEKÇİN GÜLEÇ D Toxoplasma gondii, ruh sağlığı ve şizofreni. TSK Koruyucu Hekimlik Bülteni. 2013; 12(2): 199 - 208.
IEEE CEVİZCİ S,Babaoğlu Ü,ÖTEKÇİN GÜLEÇ D "Toxoplasma gondii, ruh sağlığı ve şizofreni." TSK Koruyucu Hekimlik Bülteni, 12, ss.199 - 208, 2013.
ISNAD CEVİZCİ, Sibel vd. "Toxoplasma gondii, ruh sağlığı ve şizofreni". TSK Koruyucu Hekimlik Bülteni 12/2 (2013), 199-208.